The embryonic stem cell test (EST) has been designed to predict developmental toxicity based upon compound-induced inhibition of embryonic stem cell (ESC) differentiation. The end point scoring, the test duration, and the definition of the predictivity and the applicability domain require improvements to facilitate implementation of the EST into regulatory testing strategies. The use of transcriptomics to study compound-induced differentiation modulation may improve the EST in each of these aspects. ESC differentiation was induced, and cell samples were collected after 0, 24, and 48 h of differentiation. Additionally, samples were collected that were 24 h exposed to one of five developmentally toxic compounds or a nondevelopmentally toxic compound. All samples were hybridized to Affymetrix GeneChips, and analyses revealed that 26 genes were significantly regulated both during ESC differentiation and by exposure to each of the developmentally toxic compounds tested. Using principal component analysis, we defined a ''differentiation track'' on the basis of this gene list, which represents ESC differentiation. We showed that significant deviation from the differentiation track was in line with the developmental toxic properties of the compounds. The significance of deviation was analyzed using the leave-one-out cross-validation, which showed a favorable prediction of toxicity in the system. Our findings show that gene expression signatures can be used to identify developmental toxicant-induced differentiation modulation. In addition, studying compound-induced effects at an early stage of differentiation combined with transcriptomics leads to increased objectivity in determining differentiation inhibition and to a reduction of the test duration. Furthermore, this approach may improve the predictivity and applicability domain of the EST.
The implementation of the new European Union regulation for Registration, Evaluation and Authorization of Chemicals (REACH) in 2007 will bring about the assessment of the potential toxicity of thousands of chemicals within the coming years. The current regulatory guidelines for the toxicological hazard identification require large numbers of experimental animals. As the highest number of experimental animals are currently being used in regulatory reproductive and developmental toxicology (van der Jagt et al., 2004) , the demand for in vitro alternative test methods is particularly high in that field. Various alternative testing methods for the prediction of developmental toxicity have already been developed. These tests vary from whole-embryo cultures of rat or zebrafish and organ cultures to continuous cell line-based tests, such as the embryonic stem cell test (EST) (Flint and Orton, 1984; Genschow et al., 2004; Piersma et al., 2004; Rubinstein, 2006) .
To effectively reduce the demand for experimental animals, in vitro alternative test methods need regulatory acceptance. The validation by the European Centre for Validation of Alternative Methods (ECVAM) of the EST, the rat wholeembryo culture, and the micromass as alternative testing methods has been an important exercise toward this regulatory acceptance so far. Of these three tests, the EST is the only one that is completely animal free. However, although the EST is considered a promising alternative assay for developmental toxicity, it has several weaknesses as recently discussed in an ECVAM Workshop (Marx-Stoelting et al., 2009) . Aspects that need optimization to allow successful regulatory implementation include culture duration, end point scoring, and the definition of its predictivity and its applicability domain.
The EST predicts developmental toxicity based on the inhibition of the differentiation of embryonic stem cells (ESC) into cardiomyocytes. However, besides these mesodermalderived cardiomyocytes, cells derived from both the ectodermal and the endodermal germ layers also develop within these differentiation cultures (Doetschman et al., 1985; Leahy et al., 1999) . This resembles the in vivo situation in which cells from each of these three germ layers are present in the developing embryo (Larsen, 2001) . The prediction of developmental toxicity by the EST could possibly be optimized if compoundinduced interference with each of the cell types present in the embryoid bodies (EB) would be taken into account.
The use of molecular techniques in toxicology has enabled the early detection of changes in gene and protein expression (Baker et al., 2001; Beigel et al., 2008) . In addition, these methods can help in our understanding of the mechanisms of action of toxicity (Baken et al., 2006; Hamadeh et al., 2002) . Small-scale molecular techniques, such as real-time polymerase chain reaction (qPCR), can be used to study modulations of the expression of specific genes by a toxicant expected on the basis of knowledge of the mode of action. More advanced techniques, including transcriptomics, can be used to study gene expression alterations in the whole genome, not necessarily requiring prior mechanistic knowledge. The transcriptomics technique has shown promising results in toxicology. Waring et al. (2001) revealed a correlation between gene expression profiles of hepatoxins and mechanisms of toxicity. In the field of developmental toxicology, Robinson et al. (2009) and Jergil et al. (2009) showed that compound-induced gene expression changes in in vivo and in vitro systems, respectively, were related to teratogenic effects observed in vivo.
The implementation of transcriptomics in the EST may optimize this test as a successful in vitro model for predicting developmental toxicity. Analyses of gene expression changes have shown to be feasible within an abbreviated experimental protocol (van Dartel et al., 2009a (van Dartel et al., , 2010 . Furthermore, ESC differentiation-related genes have been identified in these studies, which could help us to define the applicability domain and improve the predictivity of the EST.
In this study, we investigated the possibility of predicting developmental toxicity by the implementation of transcriptomics into the EST. We applied principal component analysis (PCA) of gene expression dynamics to define the differentiation track in differentiating ESC in the EST protocol as previously described (van Dartel et al., 2010) . In the present study, we show that five developmental toxicants caused significant deviation from the differentiation track, whereas a nondevelopmental toxic negative-control compound did not deviate from the differentiation track. We identified a set of 26 differentiation-regulated genes, of which the expression was changed both during ESC differentiation and after exposure to each of the five developmental toxicants but not necessarily after exposure to the nondevelopmentally toxic compound. Moreover, application of the leave-one-out method showed a favorable prediction of toxicity in the system. These findings show that gene expression signatures can be used to describe and possibly predict developmental toxic responses in the EST. Resazurin cell proliferation assay. Compound-induced effects on cell number were determined using resazurin dye reduction, which is a measure for the number of viable cells per well (O'Brien et al., 2000) , as described previously (van Dartel et al., 2009b) . In short, hanging drop cultures were set up using pluripotent murine D3 ESC (ATCC, Rockville, MD) and exposed to a concentration range of the selected test compounds. After 3 days, EB were harvested per compound concentration and resazurin (Promega, Madison, WI) was added to the cells. The resazurin reduction by the cells was measured after incubation at 37°C at 530 nm (excitation) and 590 nm (emission) using a FLUOstar Galaxy microplate reader (BMG Lab Technologies, Offenburg, Germany). The resazurin reduction of exposed cells relative to control measurement was calculated and plotted against the test concentrations using PROAST software (Slob, 2002) . For each compound, a minimum of five concentrations were tested in three independent runs. The cell survival at the concentration used in the transcriptomics experiment was calculated for each compound on the basis of the curve fit.
MATERIALS AND METHODS
Pluripotent ESC culture and cardiomyocyte differentiation. D3 ESC were cultured in a monolayer in complete medium supplemented with leukemia inhibitory factor (LIF; Chemicon, Temecula, CA), as described previously (Anon, 1999; van Dartel et al., 2010) . EB were obtained via hanging drop culture in complete medium without LIF (Anon, 1999; De Smedt et al., 2008; van Dartel et al., 2010) as is visualized in Figure 1 . These EB cultures were used as the primary step for ESC differentiation. The cardiomyocyte differentiation was considered successful if in at least 21 of the 24 evaluated control EB, at least one contracting focus was present.
Inhibition of cardiomyocyte differentiation by compound exposure. ESC differentiation cultures were exposed from the EB stage at day 3 onward to concentrations that were calculated (on the basis of historic data) to inhibit cardiomyocyte differentiation with 50% compared with control cultures. All cultures were exposed to 0.2% DMSO for comparability reasons. Cultures were microscopically evaluated at day 10 of the culture to assess the inhibition of cardiomyocyte differentiation (Fig. 1) , whereas parallel cultures were used for gene expression analysis at earlier time points as explained below.
RNA isolation and whole-genome gene expression profiling. RNA of compound-exposed cultures was isolated 24 h after the start of exposure, which corresponds with culture day 4 (six to eight replicates per group). DMSOexposed control differentiation cultures were harvested after 0, 24, and 48 h from the EB stage at day 3, which corresponds with culture days 3, 4, and 5 (12 replicates per group) as is visualized in Figure 1 . Cells were directly collected in RNA protect (Qiagen, Venlo, The Netherlands) to stabilize RNA, and total RNA was purified using the RNeasy Mini Kit (Qiagen) with an additional DNase treatment (RNase-Free DNase Set; Qiagen) according to the manufacturer's instructions. The quantity of RNA in each sample was measured using a NanoDrop Spectrophotometer (NanoDrop technologies, Wilmington, DE), and RNA integrity was assessed on the 2100 Bioanalyzer (Agilent Technologies, Amstelveen, The Netherlands) using the RNA 6000 Nano Chip Kit (Agilent Technologies), and good-quality RNA was used for gene expression analysis (RNA integrity number > 8). Of the corresponding RNA samples, 250 ng was amplified and fragmented using the Affymetrix GeneChip 3#IVT Express Kit (Affymetrix, Santa Clara, CA) according to manufacturer's instructions on the Xiril Neon 150 robotic system (GC-Biotech, Alphen a/d Rijn, The Netherlands). Next, 250 ll hybridization cocktail was added to 12.5 lg fragmented aRNA, and 200 ll of this cocktail was applied to the Mouse Genome 430 2.0 Arrays (Affymetrix) and hybridized for 16 h at 45°C in a GeneChip Hybridization Oven 640 (Affymetrix). After hybridization, the arrays were washed and stained with a GeneChip Fluidics Station 450 (Affymetrix) using the GeneChip Hybridization Wash and Stain Kit. Thereafter, the arrays were scanned using the GeneChip Scanner 3000 TRANSCRIPTOMICS-BASED EMBRYOTOXICITY TESTING USING STEM CELLS (Affymetrix). Quality controls were performed according to the manufacturer's instructions and showed to be within acceptable limits for all arrays, except for one RA-exposed sample that was excluded for further analysis.
Data analysis and statistics. Affymetrix CEL files were normalized using the Robust Multichip Average (RMA) algorithm using RMAexpress (Bolstad et al., 2003) . For probe to gene mapping, a custom Common Data Format (CDF) was used according to the recent assembly by de Leeuw et al. (2008) (http://mad-db.science.uva.nl/~wdeleeuw/HybridAnnot /version6.html). Of the hybrid probe-set definitions included in the custom annotation, 16,331 probe sets defined by the Brainarray custom CDF version 11 (http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF) (Dai et al., 2005) and 4648 additional probe sets defined by Affymetrix chip annotation 26 were used in further analyses, giving a total of 20,979 probe sets. Probe sets for Affymetrix internal controls or probe sets that did not correspond to an Entrez Gene ID were not used in further analyses. Raw and normalized data are deposited at ArrayExpress (http://www.ebi.ac.uk/arrayexpress) under accession number E-TABM-903.
Statistical analyses were carried out using the R statistical software environment (http://www.R-project.org) using log-transformed values. For each gene, maximal fold ratios (FR) in gene expression between the experimental groups were determined by comparing the average normalized signal values per group and were calculated as the maximum/minimum ratio. Genes that were differentially expressed between any of the experimental groups were identified by a one-way ANOVA on the normalized data. A p significance threshold of 0.001 and FR > 1.5 were used to select genes that were significantly differentially expressed when ESC differentiate. A p < 0.001 without FR restriction was applied for the identification of significantly differentially expressed genes caused by compound exposure.
Arrangement of the genes that were significantly differentially expressed in the ESC differentiation cultures in expression clusters was achieved by hierarchical clustering based on Euclidean distance and Ward linkage using GeneMaths XT (Applied Maths, Sint-Martens-Latem, Belgium). Functional annotation and enrichment for Gene Ontology (GO) biological processes were studied using the tools on the DAVID Web site (Huang da et al., 2007) . Only genes with FR > 1.5 were used to study this enrichment because of DAVID's limitation on the length of the gene list input. In order to perform functional annotation of individual genes, we used the Entrez gene database on the NCBI Web site (http://www.ncbi.nlm.nih.gov/gene/).
Definition of the differentiation track. Using the genes significantly differentially expressed in ESC differentiation, we defined the differentiation track of normal ESC differentiation as we described previously (van Dartel et al., 2010) . This approach is based on PCA (Pearson, 1901) , which is a mathematical algorithm that describes the data on the basis of their (dis)similarity so that a greater distance corresponds with a greater dissimilarity. In this analysis, a principal component is defined as a mathematically derived combination of genes and their expression characteristics that can be used to describe part of the process observed. A number of principal components that are mutually independent can be derived which in combination describe the process under study. At first, a gene list was defined, which comprised the genes that were identified to be significantly differentially expressed among the ESC differentiation groups sampled at different stages of ESC differentiation. Next, PCA analysis was performed using this gene list using R. We connected a line between the average array gene expression at 0, 24, and 48 h on our PCA plot to display the continuous representation of the ESC differentiation based on the dynamics of gene expression. This curve was defined as the ''differentiation track.'' Later, the number of genes on this list was reduced by selecting the genes that were both regulated in ESC differentiation and by compound exposure. Finally, this refined gene list was used to describe the ESC differentiation by means of the PCA-derived differentiation track. Coordinates along the first and second principal components were calculated for each sample. Deviation of compound-exposed cultures from the differentiation track was analyzed by applying a Hotelling t-test to these coordinates compared with those of time-matched control cultures. Significant deviation from the differentiation track (p < 0.05) was considered characteristic for developmental toxicants.
To cross-validate the classification by the obtained gene list using the differentiation track approach, we used the leave-one-out validation test. Expression data of compound-exposed experimental groups were left out one by one to obtain the genes that were regulated in ESC differentiation as well as after exposure to all other developmental toxicants. These gene lists were used to define the differentiation track, and for each compound-exposed experimental group, the statistical significance of deviation from these differentiation tracks was calculated.
RESULTS

Compound-Induced Effects on Cell Proliferation and
Differentiation Differentiating ESC were exposed to single test compound concentrations, selected on the basis of historic data from our laboratory. Effects on proliferation and differentiation were scored in cultures parallel to those analyzed for gene expression. The effects on proliferation at day 3 of hanging drop culture and on cardiac foci scoring at termination (day 10) of EST culture are given in Figure 2 . PenG, VPA, and MBP did not affect cell survival, whereas RA, MAA, and 5-FU reduced cell numbers in varying degrees. All compounds affected differentiation, with PenG and VPA as the least effective Hanging drop cultures containing a suspension of single ESC were set up at day 0. The dissociated cells formed EB, which were transferred to suspension culture plates at day 3. At day 5, EB were plated one per well into 24-well tissue culture plates. At day 10, each EB was microscopically evaluated for the presence of contracting cardiomyocyte foci. Differentiating cells were exposed to test compounds from day 3 onward. For transcriptomics analysis, nonexposed control samples were isolated after 0, 24, and 48 h of exposure, and compound-exposed cultures were sampled after 24 h of exposure.
132 VAN DARTEL ET AL. compound and 5-FU as the most effective compound tested. The remaining three compounds showed differentiation inhibition of around 50%.
Differentiation-Related Gene Expression Changes
The gene expression profiles of the samples of unexposed differentiation cultures at 0, 24, and 48 h were compared by means of a one-way ANOVA analysis using cutoff criteria of p < 0.001 (corresponding false discovery rate ¼ 0.0017) and FR > 1.5. We identified 3579 genes showing statistically significant differential expression with time. This gene expression pattern showed the dynamics of early cardiomyocyte differentiation as shown in Figure 3A . Broadly, three main gene clusters were observed based on the gene expression dynamics of the differentiating ESC, representing the highest differential gene expression values among the time points studied. These gene clusters were enriched for developmental related terms, including cell differentiation (0 h), somitogenesis (24 h), developmental process (24 and 48 h), and tube development (48 h). The gene cluster upregulated at 0 h was also enriched for cell proliferation and metabolism. Furthermore, the term extracellular matrix was found to be significantly related to the identified gene cluster at 48 h (Fig. 3A) .
PCA, using the 3579 transcriptionally responsive genes, showed that 94.0% of all variance between the unexposed experimental groups could be described using only two principal components of the PCA (Fig. 3B ). Additional principal components had a minor contribution to total gene expression variance and produced no significant shifts between these experimental groups. The PCA plot clearly shows the differentiation dynamics and indicates that the variance within experimental groups is relatively very small compared with the variance between time points in ESC differentiation (Fig. 3B) . In addition, the experimental time points appeared in chronological order in the PCA plot, and a curve connecting these points showed a continuous PCA trajectory, which can be considered as the differentiation track. 
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Compound-Induced Gene Expression Changes
Comparison of the gene expression profiles of the compound-exposed experimental groups with the time-matched control group revealed the significantly differentially expressed genes per treatment (p < 0.001; Table 1 ). The highest numbers of genes were affected by exposure to MAA (8477 genes) and 5-FU (7839 genes). Furthermore, the expression of a relatively high number of genes was changed after exposure to VPA (4069 genes), RA (3276 genes), and MBP (918 genes), whereas the nondevelopmental toxicant PenG exposure altered the regulation of only 486 genes.
GO enrichment revealed downregulation of developmental related processes for all exposures, except for cultures exposed to MBP and to the negative control PenG. Besides this downregulation, developmental related processes were also upregulated in RA-and VPA-exposed cultures, such as pattern specification process (RA), regionalization (RA), and neurite development (VPA), which is clearly indicative for these compound-induced differentiation disturbances. Among the downregulated genes in MAA-and 5-FU-exposed cultures, we observed a significant enrichment in proliferation-related genes, which is in line with their observed decrease in cell number after exposure.
For all developmental toxicant-exposed groups, a significant proportion (23-36%) of the regulated genes showed overlap with the 3579 genes that were found to be differentially expressed in ESC differentiation (Table 1) , whereas this percentage of common genes was limited to 18% in PenGexposed cultures. Evaluating the common genes regulated by compound exposure and by differentiation using only the more extensively regulated genes (FR > 1.5) supported these observations. At least 50% of the genes regulated by developmental toxicants shared overlap with the genes regulated in differentiation. In contrast, in the PenG-exposed cultures, no single gene was regulated with FR > 1.5, and subsequently, no overlap could be calculated (data not shown).
Moreover, significant overlap was found between the significantly differentially expressed genes of any two compounds tested (Table 1) .
Compound-Induced Deviation from Differentiation Track
Differentiation modulation by compound exposure was further studied using the differentiation track approach. First, the deviation from time-matched nonexposed cultures was calculated for all exposed groups ( Table 2 ). The significance levels of the p values correlated with the level of differentiation inhibition observed via morphological scoring. The cardiomyocyte differentiation of cultures exposed to VPA was only decreased to 73.5%; this was mimicked by the borderline nonsignificant deviation of this experimental group from the differentiation track (p ¼ 0.053). On the other hand, the high significance values for 5-FU and MAA also correlated with their strong inhibition of the differentiation in parallel cultures scored for morphology at day 10.
Second, we defined a minimal subset of genes regulated in both ESC differentiation and by exposure to each of the developmental toxicants. Using these criteria, we defined a subset of 26 of the 3579 genes that were changed during differentiation (Table 3) . Gene functions in the gene set include development, transcription, and cellular proliferation. For 10 of the 26 genes, no information about gene function was available.
Gene expression dynamics of differentiating ESC could effectively be visualized in a PCA plot using the subset of 26 genes (Figs. 4A and 4B ). The deviation of the compoundexposed differentiation cultures from the differentiation track based on these 26 genes was calculated and visualized (Table 2 , Fig. 4B ). Using the subset of 26 genes, all developmental toxicants deviated significantly from their time-matched controls on the differentiation track. Furthermore, the negative developmental toxicant, PenG, showed no statistically significant deviation from the 24-h controls on the differentiation track. 
Leave-One-Out Prediction of Developmental Toxicity
We analyzed the predictivity of this gene expression data set for the compounds tested by a leave-one-out cross-validation (Table 2) . Gene subsets were derived composed of the genes that were both regulated in ESC differentiation and by all compounds except the one left out. This resulted in gene subsets of 29 (MAA left out) to 220 (MBP left out) commonly affected genes. Testing the left-out compound on the basis of the gene set generated with the remaining compounds showed that all developmental toxicants studied were scored as significantly deviating from the time-matched controls on the differentiation track (Table 2 , numbers in bold) except for MBP (p ¼ 0.066). The significance of differentiation track deviation of the remaining 25 experimental groups were in line with their expected developmental toxicity except for two of the predictions related to the nondevelopmental toxicant PenG, with p values of 8.4E-03 and 0.020, respectively.
DISCUSSION
In the present study, we have applied transcriptomics as a tool to study ESC differentiation and its modulation by a variety of developmental toxicants. We hypothesized that differential gene expression would objectivate effect assessment in the EST. In addition, predictivity might potentially be improved and the applicability domain expanded as gene expression changes include all cell lineages present in the culture. Finally, with this approach, culture duration could be abbreviated. Because transcriptomics has been shown to be an attractive approach to study the toxicity of compounds (Jergil et al., 2009; Robinson et al., 2009; van Dartel et al., 2010; Waring et al., 2001) , we further studied the implementation of this technique in the EST to improve the model in the abovementioned aspects.
Genes Transcriptionally Responsive to ESC Differentiation
In the present study, we uncovered more than 3500 genes that were regulated in response to ESC differentiation, and this expands the findings of previous microarray studies (Behfar et al., 2007; Beqqali et al., 2006; Christoforou et al., 2008; Masino et al., 2004; van Dartel et al., 2009a van Dartel et al., , 2010 . The enrichment of this group of genes for developmental related processes, including cell differentiation, gastrulation, and tube development, confirms that our model shares important characteristics with in vivo development. These genes may thus provide a good basis for developing a gene set that could be used as a biomarker for developmental toxicity prediction.
Furthermore, despite fundamental differences in experimental design with our previous studies (van Dartel et al., 2009a Dartel et al., , 2010 , a large fraction (84.2 and 70.5%, respectively) of the genes regulated in early ESC differentiation in those studies were also present in the set of 3579 genes identified in the present study. In addition, a similar pattern of ESC expression dynamics in time and GO enrichment was observed in the current study compared with our previous studies, which illustrates the robustness of this differentiation model.
Compound-Induced Gene Expression Changes
All compounds tested in the present study induced alterations in gene expression; however, major differences in the number of the regulated genes and the extent of regulation were present. The negative control PenG caused the regulation of 486 genes; however, the induction of those genes was modest, i.e., no genes were regulated with an FR > 1.5. In contrast, the developmental toxic exposures caused a high number of genes to be regulated and at a higher induction magnitude.
5-FU and MAA, which were demonstrated to affect cell survival and proliferation at the tested concentration, caused large alterations in individual gene expression. Analyses of the Note. The values in bold indicates prediction of effectiveness of left-out compound based on data of the remaining compounds.
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significantly regulated genes revealed that the downregulated genes were enriched for proliferation-related processes. This confirmed that 5-FU and MAA affected cell survival and/or proliferation as is known from literature (Danenberg et al., 1974; Rasjad et al., 1991; Santi et al., 1974; Stedman and Welsch, 1989) . In addition, 5-FU and MAA exposure also affected developmental related processes, which confirms their modulating effects on the ESC differentiation process. Although 5-FU and MAA may indirectly affect differentiation via inhibition of cell proliferation, the detection of such compounds as developmental toxicants is of great relevance. RA, VPA, and MBP caused the regulation of a relatively high number of genes, which was associated with their differentiation-modulating activities as observed via microscopical evaluation of ESC differentiation cultures. GO enrichment analyses using these regulated genes revealed that both upregulated and downregulated genes in RA-and VPAexposed cultures were significantly enriched for developmental related processes. This clearly illustrates the differentiationmodulating properties of these compounds as described earlier (Cotariu and Zaidman, 1991; Durston et al., 1989; Rutledge et al., 1994) . In contrast, MBP-exposed cultures did not reveal disruption of developmental related processes using these enrichment analyses. We showed previously that incomplete functional annotation of differentiation-related genes may hamper detection of gene function enrichment using standard GO-based tools, including DAVID (van Dartel et al., 2009a) . Therefore, in that study, we defined a novel defined gene set involved in early differentiation to successfully identify the MBP-induced differentiation modulation. This present study also shows regulation of a large portion of ESC differentiationrelated genes by MBP (23%). This confirms that customized gene sets have a significant added value in revealing differentiation modulation using genes that are subtly but significantly regulated.
Detection of Developmental Toxicity Using the Differentiation Track
Although developmental toxicants may cover a wide range of possible mechanisms of action, several studies have shown that many developmental toxicants tested shared the ability to modulate cardiomyocyte differentiation in the EST (Chapin et al., 2007; Genschow et al., 2004; Paquette et al., 2008) . Therefore, to identify developmental toxicants, we focused on the compound-induced regulation of differentiation-related genes in the EST. In our previous study, we showed that developmental toxicants could be identified using differential gene expression (van Dartel et al., 2010) . We employed the PCA-derived differentiation track method to identify developmental toxicants using genes that were transcriptionally responsive to cardiomyocyte differentiation of ESC. In that study, genes were used that were regulated during the first 96 h of ESC differentiation; however, additional analyses showed that the later time points were less informative for the identification of compound-induced differentiation modulation. Using the genes regulated during the first 48 h of differentiation only improved the significance of deviation from the differentiation track of the developmental toxicants studied. Therefore, in the current study, gene expression during the first 48 h of differentiation only was investigated. Here, the 3579 ESC differentiation-responsive genes were used to derive the PCA-defined differentiation track. Developmental toxicantexposed groups appeared to deviate significantly from the timematched controls on this track, confirming the modulations of the differentiation process. Selection of those genes that were both transcriptionally responsive in ESC differentiation and to exposure to each of the developmental toxicants studied resulted in a set of only 26 genes. Importantly, these genes described a similar differentiation track compared with the 3579 genes during the 48-h period of ESC differentiation studied. Using the refined set of 26 genes, the significance of deviation from the time-matched controls on the differentiation track appeared to be in line with the developmental toxic properties of the tested compounds, and for all compounds tested, the significance of deviation was increased compared with the analysis based on all 3579 developmental genes. Further studies are needed to establish whether this descriptive gene set is indeed predictive for other developmental toxic compounds.
Leave-One-Out Cross-Validation
We applied the commonly used cross-validation according to the leave-one-out principle to get a first impression of the predictivity of our gene expression approach. This validation showed that each compound, when its data were not included in refining the gene set, deviated significantly from the timematched controls on the differentiation track, indicating that it was correctly predicted as a developmental toxicant on the basis of the remainder of the data. As the single exception, the deviation of MBP-exposed cultures from its time-matched controls was borderline nonsignificant (p ¼ 0.066). This MBP analysis was performed using 220 genes, 194 genes more compared with the 26 genes of the refined gene list. The relatively mild effects of MBP on the additional genes caused the borderline nonsignificant deviation of this experimental group. In addition, the significance values of other compounds tested against these leave-one-out gene sets showed to be in line with their developmental toxic properties with only two exceptions. Altogether, the leave-one-out cross-validation resulted in correct significance values for track deviations in 27 of 30 cases, thereby demonstrating the robustness of the approach.
A significant improvement of the differentiation track approach compared with the ''classical EST'' is that effects on genes of various differentiation-related processes are included in the analysis, although the classical EST focuses exclusively on inhibition of cardiomyocyte differentiation. In our previous work, we showed that MBP and 6-aminonicotinamide, both mainly affecting structures of mesodermal origin, could be identified using the differentiation track approach (van Dartel et al., 2010) . In the current study, we studied the wider applicability of this approach using compounds that do not only specifically affect mesodermalderived tissues. RA and VPA mainly affect ectodermal-derived TRANSCRIPTOMICS-BASED EMBRYOTOXICITY TESTING USING STEM CELLS tissues (Cotariu and Zaidman, 1991; Durston et al., 1989) . Furthermore, also compounds that induce developmental toxic effects via effects on cell survival and proliferation, 5-FU and MAA (Danenberg et al., 1974; Rasjad et al., 1991; Santi et al., 1974; Stedman and Welsch, 1989) , were included, as well as a negative control (PenG). The identification of differentiation modulation of these diverse developmental toxicants shows that the applicability domain of EST with our new approach is not limited to compounds specifically affecting mesodermalderived tissues.
This study as well as other studies show that gene expression changes are a function of compound concentration (Andersen et al., 2008; Goetz and Dix, 2009 ). In the present study, developmental toxicants were tested at single concentrations inhibiting cardiomyocyte differentiation. Also, in other studies, single concentrations were selected that are known to induce effects on classical end points (Auerbach et al., 2010; Jonker et al., 2009) . Auerbach et al. (2010) used two concentrations for assessment of carcinogenic activity when evaluating chemicals with unknown carcinogenic potency, which improved the assessment of potential carcinogenicity. Dose-response analysis will be important in future studies to refine our model and to improve the identification of developmental toxicants.
In conclusion, these findings are promising in terms of the prospect of using gene expression profiling in combination with ESC differentiation models in order to predict developmental toxicity. The PCA-derived differentiation track proved to be a suitable concept for use in the dynamic ESC differentiation system as modulation of gene expression correlating with ESC differentiation by developmental toxicants was robustly detected. Further development, standardization, and validation of this model are needed via testing of gene expression modulation of additional compounds in a dose-response design. Additional key genes could be identified in subsequent studies, which may further improve the prediction of developmental toxicity in the model. Enhancing predictivity, throughput, and applicability domain are key aspects that may be improved through this approach, facilitating its incorporation as a test system for developmental toxicity in regulatory toxicology. 
